MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.psychres.2026.117184

Медицинская библиотека · Psychiatry research · 2026

Faster and greater antidepressant response to intravenous ketamine in bipolar compared with unipolar treatment-resistant depression: Diagnostic and sex-related findings from a naturalistic study.

Carmellini Pietro, Fagiolini Andrea, Pinzi Mario, Magno Marta, Martella Donato, Nicchi Lorenzo, Rescalli Maria Beatrice, Tarantino Francesca, Tinturini Rebecca, Scheggi Simona, Gualtieri Giacomo, Cuomo Alessandro

СтатьяНаблюдательное исследованиеСравнительное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Intravenous ketamine has emerged as a rapid-acting antidepressant intervention that has shown promising effects in patients with treatment-resistant depression, although evidence remains heterogeneous and less well established across diagnostic subtypes. Nevertheless, real-world data comparing diagnostic subtypes and sex-related differences remain limited. This observational study examined the antidepressant efficacy, tolerability, and dissociative effects of intravenous ketamine in patients with treatment-resistant unipolar depression (TRD) and treatment-resistant bipolar depression (TRBD) in a naturalistic clinical setting.

METHODS

Ninety-seven adult patients meeting DSM-5 criteria for unipolar or bipolar depression received racemic intravenous ketamine at a university psychiatric center. Depressive symptoms and global clinical severity were assessed at baseline and up to three months using the Montgomery-Åsberg Depression Rating Scale (MADRS) and the Clinical Global Impression-Severity scale (CGI-S). Dissociative symptoms were measured with the Clinician-Administered Dissociative States Scale (CADSS). Longitudinal outcomes were analyzed using mixed-effects models.

RESULTS

Both groups experienced significant reductions in depressive symptoms over time. Patients with bipolar depression demonstrated a faster and greater improvement than those with unipolar depression, with differences emerging from week 2 and persisting through three months. CGI-S scores showed a comparable pattern. The dissociative symptoms showed no change throughout the study and they appeared at the same level in all diagnostic categories. Sex-stratified analyses revealed no differences in antidepressant efficacy, although women with unipolar depression exhibited higher dissociative symptoms at three months.

CONCLUSIONS

Intravenous ketamine is effective in real-world treatment-resistant depression, with superior and more sustained antidepressant effects in bipolar compared with unipolar depression.

Для цитирования: Carmellini Pietro, Fagiolini Andrea, Pinzi Mario, Magno Marta, Martella Donato, Nicchi Lorenzo, Rescalli Maria Beatrice, Tarantino Francesca, Tinturini Rebecca, Scheggi Simona, Gualtieri Giacomo, Cuomo Alessandro. Faster and greater antidepressant response to intravenous ketamine in bipolar compared with unipolar treatment-resistant depression: Diagnostic and sex-related findings from a naturalistic study.. Psychiatry research. 2026. DOI: 10.1016/j.psychres.2026.117184.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.